AEPCX
Price
$62.77
Change
+$0.52 (+0.84%)
Updated
Oct 3 closing price
Net Assets
138.77B
AFCWX
Price
$18.66
Change
+$0.05 (+0.27%)
Updated
Oct 3 closing price
Net Assets
158M
Interact to see
Advertisement

AEPCX vs AFCWX

Header iconAEPCX vs AFCWX Comparison
Open Charts AEPCX vs AFCWXBanner chart's image
American Funds EUPAC C
Price$62.77
Change+$0.52 (+0.84%)
VolumeN/A
Net Assets138.77B
American Century Focused Intl Gr R
Price$18.66
Change+$0.05 (+0.27%)
VolumeN/A
Net Assets158M
AEPCX vs AFCWX Comparison Chart in %
View a ticker or compare two or three
VS
AEPCX vs. AFCWX commentary
Oct 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Buy and AFCWX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 139B vs. AFCWX (158M). AEPCX pays higher dividends than AFCWX: AEPCX (0.16) vs AFCWX (0.00). AEPCX was incepted earlier than AFCWX: AEPCX (25 years) vs AFCWX (10 years). AFCWX (1.59) and AEPCX (1.57) have similar cost to investors . AFCWX is a more actively managed with annual turnover of: 82.00 vs. AEPCX (35.00). AEPCX has a lower initial minimum investment than AFCWX: AEPCX (250) vs AFCWX (2500). AEPCX annual gain was more profitable for investors over the last year : 10.37 vs. AFCWX (8.80). AEPCX return over 5 years is better than : 13.86 vs. AFCWX (12.55).
AEPCXAFCWXAEPCX / AFCWX
Total Expense Ratio1.571.5999%
Annual Report Gross Expense Ratio1.571.5999%
Fund Existence25 years10 years-
Gain YTD21.48217.211125%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets139B158M87,975%
Annual Yield % from dividends0.160.00-
Returns for 1 year10.378.80118%
Returns for 3 years42.8240.62105%
Returns for 5 years13.8612.55111%
Returns for 10 years39.95N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TVRD40.232.86
+7.65%
Tvardi Therapeutics Inc
OACCU10.65N/A
N/A
Oaktree Acquisition Corp III Life Sciences
GNTA3.30-0.01
-0.25%
Genenta Science SpA
IMCR34.21-1.08
-3.06%
Immunocore Holdings plc
IDCC339.10-17.00
-4.77%
InterDigital